Skip to content

Switzerland French logo

Main menu
    • À propos
    • Notre vision, raison d’être, et mission
    • Nos engagements RSE
    • Transparence chez Organon
  • Nos domaines d’intervention
  • Espace Presse
  • Nous rejoindre

Contact

Retour
Change Language
  • Deutsch
  • English
Main menu

Organon site directory

  • Organon

    • Brazil
    • Canada  English  ·  French
    • Latin America
    • Mexico
    • USA
  • Organon

    • Austria
    • Belgium  Dutch  ·  English  ·  French
    • Bulgaria
    • Czech Republic
    • Denmark
    • Estonia
    • Finland
    • France
    • Germany
    • Hungary
    • Ireland
    • Italy
    • Latvia
    • Lithuania
    • Luxembourg  English  ·  French
    • Netherlands  Dutch  ·  English
    • Norway
    • Poland
    • Portugal
    • Romania
    • Russia
    • Serbia
    • Slovakia
    • Slovenia
    • Spain
    • Sweden
    • Switzerland  French  ·  German  ·  English
    • Ukraine  Ukrainian  · 
    • United Kingdom
  • Organon

    • Australia
    • Hong Kong, China
    • Indonesia
    • Japan
    • Malaysia
    • New Zealand
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Organon

    • Egypt
    • Israel
    • Jordan
    • KSA
    • Kuwait
    • Lebanon
    • Northwest Africa  French  ·  Arabic  ·  Turkey
    • Oman
    • South Africa
    • Turkey
    • UAE
View all locations and contact information

What can we help you find?

Search for:

La santé au féminin, notre engagement quotidien.

Protéger, prendre soin et accompagner.

Améliorer la santé de chaque femme et faire que chaque jour soit un meilleur jour.

Notre raison d’être

Nous savons que les femmes sont essentielles à un monde en meilleure santé. Notre raison d’être est d’accompagner les femmes tout au long de leur vie et leur permettre de faire les bons choix en matière de santé. Nous sommes animés par la recherche de solutions innovantes pour répondre à des besoins médicaux toujours non satisfaits.

Notre vision, raison d’être, et mission

Nos domaines d’intervention

Nous disposons d’un portefeuille solide et diversifié de plus de 60 médicaments et solutions thérapeutiques couvrant un large éventail de pathologies : contraception, fertilité, maladies cardiovasculaires, cancers, douleur, pneumologie, neurologie, migraine. Nous nous efforçons de rendre ces thérapies accessibles dans le monde entier, fort de notre dimension internationale, au service des patients de plus de 140 pays.

Illustration d’une femme arrosant une plante

Santé des femmes

Illustration d’une maman prenant soin de ses enfants

Marques historiques

Illustration d’une femme vaillante avec une jambe cassée

Biosimilaires

Espace Presse

Consultez nos dernières nouvelles et téléchargez les ressources dont vous avez besoin.

Espace Presse

Carrière

Ensemble, nous sommes à l’écoute des femmes pour comprendre leurs besoins en matière de santé, dans le but de proposer des solutions ingénieuses aux différentes étapes de leur vie.

Nos fondateurs sont unis dans leur volonté d’œuvrer pour la santé des femmes.

Rejoindre nos équipes

CH-NON-110127 – February 2025

Switzerland French logo
  • Mentions légales
  • Conditions d’utilisation
  • AGB
  • Politique en matière de cookies
  • Politique de confidentialité
© 2025 Organon group of companies. All rights reserved.

You are leaving Organon.com

Cancel Continue Opens a new window

Forward-looking statement of Organon

This news release of Organon (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of the recent global outbreak of novel coronavirus disease (COVID-19); the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2020 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov Opens a new window ).

No Duty to Update

The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.

Decline Accept